These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11383716

  • 21. Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120.
    Fischetti C, Rizzi A, Gavioli EC, Marzola G, Trapella C, Guerrini R, Petersen JS, Calo G.
    Peptides; 2009 Feb; 30(2):248-55. PubMed ID: 18992780
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.
    Calò G, Rizzi A, Bogoni G, Neugebauer V, Salvadori S, Guerrini R, Bianchi C, Regoli D.
    Eur J Pharmacol; 1996 Sep 05; 311(1):R3-5. PubMed ID: 8884244
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity.
    Guerrini R, Carra' G, Calo' G, Trapella C, Marzola E, Rizzi D, Regoli D, Salvadori S.
    J Pept Res; 2004 Jun 05; 63(6):477-84. PubMed ID: 15175020
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198.
    Ciccocioppo R, Biondini M, Antonelli L, Wichmann J, Jenck F, Massi M.
    Psychopharmacology (Berl); 2002 May 05; 161(2):113-9. PubMed ID: 11981590
    [Abstract] [Full Text] [Related]

  • 31. Effects of nociceptinNH2 and [Nphe1]nociceptin(1-13)NH2 on rat brain noradrenaline release in vivo and in vitro.
    Okawa H, Kudo M, Kudo T, Guerrini R, Lambert DG, Kushikata T, Yoshida H, Matsuki A.
    Neurosci Lett; 2001 May 11; 303(3):173-6. PubMed ID: 11323113
    [Abstract] [Full Text] [Related]

  • 32. Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice.
    Rizzi A, Bigoni R, Marzola G, Guerrini R, Salvadori S, Regoli D, Calo' G.
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb 11; 363(2):161-5. PubMed ID: 11218068
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors.
    Schlicker E, Werthwein S, Kathmann M, Bauer U.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct 11; 358(4):418-22. PubMed ID: 9826063
    [Abstract] [Full Text] [Related]

  • 35. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
    Bigoni R, Rizzi D, Rizzi A, Camarda V, Guerrini R, Lambert DG, Hashiba E, Berger H, Salvadori S, Regoli D, Calo' G.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun 11; 365(6):442-9. PubMed ID: 12070757
    [Abstract] [Full Text] [Related]

  • 36. Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices.
    Siniscalchi A, Rodi D, Beani L, Bianchi C.
    Br J Pharmacol; 1999 Sep 11; 128(1):119-23. PubMed ID: 10498842
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.
    Flau K, Redmer A, Liedtke S, Kathmann M, Schlicker E.
    Br J Pharmacol; 2002 Dec 11; 137(8):1355-61. PubMed ID: 12466246
    [Abstract] [Full Text] [Related]

  • 38. Pharmacological studies on the "orphan" opioid receptor in central and peripheral sites.
    Nicholson JR, Paterson SJ, Menzies JR, Corbett AD, McKnight AT.
    Can J Physiol Pharmacol; 1998 Mar 11; 76(3):304-13. PubMed ID: 9673794
    [Abstract] [Full Text] [Related]

  • 39. [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor.
    Carrà G, Rizzi A, Guerrini R, Barnes TA, McDonald J, Hebbes CP, Mela F, Kenigs VA, Marzola G, Rizzi D, Gavioli E, Zucchini S, Regoli D, Morari M, Salvadori S, Rowbotham DJ, Lambert DG, Kapusta DR, Calo' G.
    J Pharmacol Exp Ther; 2005 Mar 11; 312(3):1114-23. PubMed ID: 15509719
    [Abstract] [Full Text] [Related]

  • 40. Functional heterogeneity of nociceptin/orphanin FQ receptors revealed by (+)-5a Compound and Ro 64-6198 in rat periaqueductal grey slices.
    Liao YY, Teng SF, Lin LC, Kolczewski S, Prinssen EP, Lee LJ, Ho IK, Chiou LC.
    Int J Neuropsychopharmacol; 2011 Aug 11; 14(7):977-89. PubMed ID: 21029514
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.